Lam Barbara D, Dodge Laura E, Datta Siddhant, Rosovsky Rachel P, Robertson William, Lake Leslie, Reyes Nimia, Adamski Alys, Abe Karon, Panoff Samuel, Pinson Amanda, Elavalakanar Pavania, Vlachos Ioannis S, Zwicker Jeffrey I, Patell Rushad
Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Res Pract Thromb Haemost. 2023 Aug 7;7(6):102168. doi: 10.1016/j.rpth.2023.102168. eCollection 2023 Aug.
Venous thromboembolism (VTE) is a leading cause of preventable mortality among hospitalized patients, but appropriate risk assessment and thromboprophylaxis remain underutilized or misapplied.
We conducted an electronic survey of US health care providers to explore attitudes, practices, and barriers related to thromboprophylaxis in adult hospitalized patients and at discharge.
A total of 607 US respondents completed the survey: 63.1% reported working in an academic hospital, 70.7% identified as physicians, and hospital medicine was the most frequent specialty (52.1%). The majority of respondents agreed that VTE prophylaxis is important (98.8%; 95% CI: 97.6%-99.5%) and that current measures are safe (92.6%; 95% CI: 90.2%-94.5%) and effective (93.8%; 95% CI: 91.6%-95.6%), but only half (52.0%; 95% CI: 47.9%-56.0%) believed that hospitalized patients at their institution are on appropriate VTE prophylaxis almost all the time. One-third (35.4%) reported using a risk assessment model (RAM) to determine VTE prophylaxis need; 44.9% reported unfamiliarity with RAMs. The most common recommendation for improving rates of appropriate thromboprophylaxis was to leverage technology. A majority of respondents (84.5%) do not reassess a patient's need for VTE prophylaxis at discharge, and a minority educates patients about the risk (16.2%) or symptoms (18.9%) of VTE at discharge.
Despite guideline recommendations to use RAMs, the majority of providers in our survey do not use them. A majority of respondents believed that technology could help improve VTE prophylaxis rates. A majority of respondents do not reassess the risk of VTE at discharge or educate patients about this risk of VTE at discharge.
静脉血栓栓塞症(VTE)是住院患者可预防死亡的主要原因,但适当的风险评估和血栓预防措施仍未得到充分利用或应用不当。
我们对美国医疗服务提供者进行了一项电子调查,以探讨与成年住院患者及出院时血栓预防相关的态度、做法和障碍。
共有607名美国受访者完成了调查:63.1%报告在学术医院工作,70.7%为医生,医院医学是最常见的专业(52.1%)。大多数受访者认为VTE预防很重要(98.8%;95%置信区间:97.6%-99.5%),当前措施安全(92.6%;95%置信区间:90.2%-94.5%)且有效(93.8%;95%置信区间:91.6%-95.6%),但只有一半(52.0%;95%置信区间:47.9%-56.0%)的人认为其所在机构的住院患者几乎一直都在接受适当的VTE预防。三分之一(35.4%)的人报告使用风险评估模型(RAM)来确定VTE预防需求;44.9%的人表示不熟悉RAM。提高适当血栓预防率的最常见建议是利用技术。大多数受访者(84.5%)在出院时不重新评估患者对VTE预防的需求,少数人在出院时对患者进行VTE风险(16.2%)或症状(18.9%)的教育。
尽管指南建议使用RAM,但我们调查中的大多数提供者并未使用。大多数受访者认为技术有助于提高VTE预防率。大多数受访者在出院时不重新评估VTE风险,也不对患者进行出院时VTE风险的教育。